Skip to main content
BIOPHARMA CREDIT PLC logo

BIOPHARMA CREDIT PLC — Investor Relations & Filings

Ticker · BPCR ISIN · GB00BDGKMY29 LEI · 213800AV55PYXAS7SY24 IL Financial and insurance activities
Open in API
Filings indexed 734 across all filing types
Latest filing 2025-04-07 Transaction in Own Shar…
Country GB United Kingdom
Listing IL BPCR

About BIOPHARMA CREDIT PLC

https://bpcruk.com/

BioPharma Credit PLC is a specialist investment trust that provides debt capital to the life sciences industry. The company's primary objective is to generate long-term, sustainable income for shareholders by investing in a diversified portfolio of interest-bearing debt assets. These investments are typically secured by royalties, revenue streams, and other cash flows derived from approved pharmaceutical products and healthcare technologies. This strategy offers investors exposure to the life sciences sector through debt instruments while providing financing to companies for growth and development.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from BioPharma Credit PLC regarding the purchase of its own ordinary shares into treasury. It details the date of purchase, number of shares, price range, and the resulting impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-04-07 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from BioPharma Credit PLC regarding the purchase of its own ordinary shares into treasury. It provides specific details such as the date of purchase, number of shares, price range, and the resulting impact on treasury shares and total voting rights. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2025-04-04 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from BioPharma Credit PLC regarding the purchase of its own ordinary shares into treasury. It details the number of shares purchased, the price per share, and the resulting total number of voting rights. This aligns perfectly with the definition of a 'Transaction in Own Shares' (POS) filing.
2025-04-03 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'TRANSACTION IN OWN SHARES' where BioPharma Credit PLC purchased 1,076,100 of its ordinary shares into treasury on April 2, 2025. This action directly corresponds to the definition of a company buying back or selling its own shares. The filing is identified by the RNS Number and contains specific details about the share repurchase, matching the criteria for 'Transaction in Own Shares' (POS). The document length is short (3188 chars), but the content is a direct announcement of the transaction itself, not an announcement about a report, thus it is classified as POS, not RPA or RNS.
2025-04-02 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'National Storage Mechanism'. The content details a 'TR-1: Standard form for notification of major holdings' regarding an acquisition of voting rights by Adage Capital Management L.P., crossing a threshold. This type of mandatory disclosure to the market, especially when originating from the London Stock Exchange's news service (RNS), falls under general regulatory announcements. Since there is a specific category for 'Major Shareholding Notification' (MRQ), that is the most precise fit, as TR-1 forms are the standard mechanism for reporting changes in major shareholdings in the UK/EU.
2025-04-02 English
BIOGEN SETTLEMENT
Regulatory Filings Classification · 98% confidence The document is a short announcement (under 5,000 characters) distributed via the London Stock Exchange's RNS (Regulatory News Service). It details the resolution of a legal dispute and the receipt of a settlement payment. While it mentions a lawsuit, it is not a formal legal proceedings report but rather a corporate announcement of a financial event. Since it does not fit into specific categories like M&A or dividend announcements, and is a standard regulatory news release, it is classified as a Regulatory Filing (RNS).
2025-04-02 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.